Athena Bioscience LLC
General
Total Cases2
Active Cases1
Patents6
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 12/30/24 | Summons Issued as to Novitium Pharma LLC on 12/27/2024. (jfm) (Entered: 12/30/2024) | |
| 12/30/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Rosemont Pharmaceuticals Inc., Other Affiliate Rosemont Pharmaceuticals Limited for Athena Bioscience, LLC filed by Athena Bioscience, LLC. (jfm) (Entered: 12/30/2024) | |
| 12/30/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US11103452 B2; US11752103 B2. (jfm) (Entered: 12/30/2024) | |
| 12/30/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/19/2024. Date of Expiration of Patent: 09/01/2040.Thirty Month Stay Deadline: 5/19/2027. (jfm) (Entered: 12/30/2024) | |
| 12/30/24 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 12/30/2024) | |
| 12/30/24 | COMPLAINT for Patent Infringement against Novitium Pharma LLC (Filing fee $ 405, receipt number ADEDC-4578769) - filed by Athena Bioscience, LLC. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Civil Cover Sheet)(jfm) (Entered: 12/30/2024) |